Abstract
Rats were trained in a three-chambered discrimination box to avoid an electric shock which was preceded by the presentation of light. Tetrabenazine, at a subcutaneous dose of 6 mg/kg suppressed this conditioned avoidance response (CAR) without abolishing the unconditioned escape response (UER). The three classes of antidepressant drugs affected differently the tetrabenazine-induced suppression of CAR. The tricyclic antidepressants, imipramine and desmethylimipramine (DMI), did not prevent the suppression of the CAR while the monoamine oxidase (MAO) inhibitors, iproniazid and pargyline did. The stimulant drugs d-amphetamine and methylphenidate, in addition to preventing also reversed the effect of tetrabenazine. The action of two experimental compounds, butriptyline and Lu3-010 was also investigated.
The results are discussed in view of a possible relationship between the maintenance of the CAR and the availability of both norepinephrine (NE) and dopamine (DA) in the central nervous system.
Similar content being viewed by others
Abbreviations
- 5-HT:
-
5-hydroxytryptamine, serotonin
- NE:
-
norepinephrine
- DA:
-
dopamine
- DMI:
-
desmethylimipramine
- MAO:
-
monoamine oxidase
- CAR:
-
conditioned avoidance response
- UER:
-
unconditioned escape response
References
Appel, J. B., Freedman, D. X.: Chemically-induced alterations in the behavioral effects of LSD-25. Biochem. Pharmacol. 13, 861–869 (1964).
Bocknik, S. E., Hingtgen, J. N., Hughes, F. W., Forney, R. B.: Harmaline effects on tetrabenazine depression of avoidance responding in rats. Life Sci. 7, 1189 to 1201 (1968).
Butcher, L. L., Andén, N.-E.: Effects of apomorphine and amphetamine on schedule-controlled behavior: reversal of tetrabenazine suppression and dopaminergic correlates. Europ. J. Pharmacol. 6, 255–264 (1969).
Carlsson, A., Fuxe, K., Hamberger, B., Lindqvist, M.: Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta physiol. scand. 67, 481–497 (1966).
Gey, K. F., Pletscher, A., Burkard, W.: Effect of inhibitors of monoamine oxidase on various enzymes and on the storage of monoamines. Ann. N. Y. Acad. Sci. 107, 1147–1151 (1963).
Gorkin, V. Z., Romanova, L. A.: On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo. Biochem. Pharmacol. 17, 855–860 (1968).
Green, H., Erickson, R. W.: Effect of trans-2-phenylcyclopropylamine upon norepinephrine concentration and monoamine oxidase activity of rat brain. J. Pharmacol. exp. Ther. 129, 237–242 (1960).
Häggendal, J.: The depletion and recovery of noradrenaline in the brain and some sympathetically innervated mammalian tissues after tetrabenazine. J. Pharm. Pharmacol. 20, 364–367 (1968).
Heise, A. G.: Behavioral analysis of tetrabenazine in animals. Dis. nerv. Syst. 21, (Suppl.) 1–4 (1960).
—, Boff, E.: Behavioral determination of time and dose parameters of monoamine oxidase inhibitors. J. Pharmacol. exp. Ther. 129, 155–162 (1960).
Kissel, J. W.: The pharmacology of MJ 1986, a phenylindene with properties of antidepressant and, psychostimulant significance. In: Antidepressant Drugs, pp. 233–240. Proc. 1st Int. Symp. Ed. S. Garattini and M. N. G. Dukes. Excerpta Medica Foundation 1966.
Levison, P. K., Freedman, D. X.: Recovery of a discriminated lever-press avoidance performance from the effects of reserpine, chlorpromazine and tetrabenazine Arch. int. Pharmacodyn. 170, 31–38 (1967).
McKearney, J. W.: The relative effects of d-amphetamine, imipramine and harmaline on tetrabenazine suppression of schedule-controlled behavior in the rat. J. Pharmacol. exp. Ther. 159, 429–440 (1968).
McNeill, J. H., Brody, T. M.: The effects of certain drugs on amine uptake and phosphorylase activation in the rat heart. Pharmacologist 9, 222 (1967).
— —: The effect of various drug pretreatments on amine-induced phosphorylase activation and amine uptake. J. Pharmacol. exp. Ther. 162, 121–133 (1968).
Moore, K.E., Rech, R. H.: Reversal of α-methyltyrosine-induced behavioral depression with dihydroxyphenylalanine and amphetamine. J. Pharm. Pharmacol. 19, 405–407 (1967).
Morpurgo, C.: Drug-induced modifications of discriminated avoidance behavior in rats. Psychopharmacologia (Berl.) 8, 91–99 (1965).
Petersen, P. V., Lassen, K, Hansen, V., Huld, T., Hjortkjaer, J., Holmblad, J., Møller Nielsen, I., Nymark, M., Pedersen, V., Jørgensen, A., Hougs, W.: Pharmacological studies of a new series of bicyclic thymoleptics. Acta pharmacol. (Kbh.) 24, 121–133 (1966).
Pletscher, A.: Release of 5-hydroxytryptamine by benzoquinolizine derivatives with sedative action. Science 126, 507 (1957).
—: Monoamine oxidase inhibitors: effect related to psychostimulation. In: Psychopharmacology, A review of progress 1957–1967, pp. 649–654. Proc. 6th Ann. Meeting of Am. Coll. Neuropsychopharmacol. Ed. D. H. Efron. Washington: Superintendent of Documents 1967.
Poschel, B. P. H., Ninteman, F. W.: Excitatory (antidepressant?) effects of monoamine oxidase inhibitors on the reward system of the brain. Life Sci. 3, 903–910 (1964).
Quinn, G. P., Shore, P. A., Brodie, B. B.: Biochemical and pharmacological studies of Ro 1-9569 (tetrabenazine), a non-indole tranquilizing agent with reserpine-like effects. J. Pharmacol. exp. Ther. 127, 103–109 (1959).
Scheckel, C. L.: Discussion. In: Antidepressant drugs of non-MAO inhibitor type. pp. 114–118. Proc. of a Workshop, Ed. D. H. Efron and S. S. Kety. U.S. Dept. of Health, Education and Welfare 1966.
Schildkraut, J. J., Davis, J. M., Klerman, G. L.: Biochemistry of depression. In: Psychopharmacology, A review of progress 1957–1967, pp. 625–648. Proc. 6th Ann. Meeting of Am. Coll. Neuropsychopharmacol. Ed. D. H. Efron. Washington: The Superintendant of Documents 1967.
Seiden, L. S., Peterson, D. D.: Reversal of the reserpine-induced suppression of the conditioned avoidance response by L-DOPA: correlation of behavioral and biochemical differences in two strains of mice. J. Pharmacol. exp. Ther. 159, 422–428 (1968).
Sigg, E. B.: Tricyclic thymoleptic agents and some newer antidepressants. In: Psychopharmacology, A review of progress 1957–1967, pp. 655–669. Proc. 6th Ann. Meeting of Am. Coll. Neuropsychopharmacol. Ed. D. H. Efron. Washington: The Superintendant of Documents 1967.
Stein, L., Seifter, J.: Indexing of centrally stimulating drugs by restoration of reserpine depressed operant behavior. Pharmacologist 2, 70 (1960).
Stretch, R., Dalrymple, D.: Effects of methylphenidate, pentobarbital, and reserpine on behavior controlled by a schedule of interresponse time reinforcement. Psychopharmacologia (Berl.) 13, 49–64 (1968).
Sulser, F., Bickel, M. H., Brodie, B. B.: The action of desmethylimipramine in counteracting sedation and cholinergic effects of reserpine-like drugs. J. Pharmacol. exp. Ther. 144, 321–330 (1964).
Voith, K., Herr, F.: Psychopharmacological evaluation of a new antidepressant: butriptyline. Arch. int. Pharmacodyn. 182, 318–331 (1969).
Zbinden, G.: Pharmacodynamics of tetrabenazine and its derivatives. In: Psychosomatic Medicine, pp. 443–454. Ed. J. H. Nodine and J. H. Moyer. Philadelphia: Lea and Febiger 1962.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Voith, K., Herr, F. The effect of various antidepressant drugs upon the tetrabenazine-suppressed conditioned avoidance response in rats. Psychopharmacologia 20, 253–265 (1971). https://doi.org/10.1007/BF00402101
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00402101